thiazoles has been researched along with saquinavir in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 21 (87.50) | 18.2507 |
2000's | 2 (8.33) | 29.6817 |
2010's | 1 (4.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Steele, F | 1 |
Anderson, B; Erickson, JW; Gulnik, SV; Liu, B; Mitsuya, H; Suvorov, LI; Yu, B | 1 |
Blum, MR; Millard, J; Painter, G; Parry, N; Rooney, J; Sadler, BM; St Clair, MH; Tisdale, M | 1 |
Schenk, M | 1 |
Blanchard, SG; Furfine, ES; Ittoop, O; Jain, RG; Lenhard, JM; Orband-Miller, LA; Paulik, MA; Weiel, JE | 1 |
Vella, S | 1 |
Baker, R | 1 |
Chang, HE | 1 |
Alcorn, K | 1 |
MacDougall, DS | 1 |
Smart, T | 1 |
Mascolini, M | 1 |
Freire, E; Vega, S; Velazquez-Campoy, A | 1 |
Branquinha, MH; d'Avila-Levy, CM; Pedroso e Silva, CM; Santos, AL; Santos, LO; Vitório, BS | 1 |
3 trial(s) available for thiazoles and saquinavir
Article | Year |
---|---|
In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents.
Topics: Carbamates; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine | 1996 |
Protease inhibitors: ritonavir and saquinavir combination trial recruiting--seven U.S., Canada sites incl. San Francisco.
Topics: Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Matching up ritonavir with saquinavir.
Topics: Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
21 other study(ies) available for thiazoles and saquinavir
Article | Year |
---|---|
AIDS drugs lurch towards market.
Topics: Acquired Immunodeficiency Syndrome; Drug Approval; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; United States; United States Food and Drug Administration; Valine | 1995 |
Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.
Topics: Amino Acid Sequence; Binding Sites; Carbamates; Cloning, Molecular; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Indinavir; Isoquinolines; Kinetics; Methylurea Compounds; Mutagenesis, Site-Directed; Oligopeptides; Point Mutation; Pyridines; Quinolines; Recombinant Proteins; Saquinavir; Structure-Activity Relationship; Thiazoles; Valine | 1995 |
New drugs for HIV infection.
Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Zalcitabine | 1996 |
A new class of anti-HIV drugs debuts.
Topics: Drug Costs; Drug Resistance; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
[For the first time a combination of 2 protease inhibitors investigated].
Topics: Antiviral Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.
Topics: Adipocytes; Animals; Azo Compounds; Bexarotene; Carbamates; Carrier Proteins; Cell Differentiation; Cells, Cultured; Coloring Agents; Fatty Acid-Binding Proteins; Furans; HIV Protease Inhibitors; Indinavir; Insulin; Lipolysis; Lipoprotein Lipase; Nelfinavir; Neoplasm Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ritonavir; RNA, Messenger; Rosiglitazone; Saquinavir; Stem Cells; Sulfonamides; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides | 2000 |
Protease inhibitor trials moving to next phase.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication | 1995 |
Update on HIV protease inhibitors.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Design; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Phosphorylation; Pyridines; Quinolines; Ritonavir; Saquinavir; Substrate Specificity; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Ritonavir, saquinavir combination--& warning.
Topics: Dose-Response Relationship, Drug; Drug Resistance, Microbial; Half-Life; HIV Infections; Humans; Inactivation, Metabolic; Isoquinolines; Mutation; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1995 |
Abbott agrees to expanded access for ritonavir.
Topics: Acquired Immunodeficiency Syndrome; Dosage Forms; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1995 |
Conference looks at HIV drug resistance.
Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine | 1995 |
Europe out of step with the US.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Costs; Europe; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Ritonavir; Saquinavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
Protease inhibitors-at-a-glance.
Topics: HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Ritonavir: first to prolong survival.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Ritonavir/saquinavir trial announced.
Topics: Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Two protease inhibitors given high expectations.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Nipping HIV in the bud.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Protease inhibitors.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Ritonavir plus saquinavir: two trials with different results.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; RNA, Viral; Saquinavir; Thiazoles; Valine | 1996 |
Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.
Topics: Africa; Amides; Amino Acid Substitution; Anti-HIV Agents; Calorimetry; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Kinetics; Mutagenesis, Site-Directed; Nelfinavir; Phenotype; Polymorphism, Genetic; Recombinant Proteins; Ritonavir; Saquinavir; Thermodynamics; Thiazoles | 2002 |
Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients.
Topics: Antiprotozoal Agents; Aspartic Acid Proteases; Colorimetry; Fluorometry; HIV Infections; Humans; Leishmania; Leishmaniasis; Microbial Viability; Nelfinavir; Oligopeptides; Saquinavir; Tetrazolium Salts; Thiazoles | 2013 |